Investment Thesis
Doximity demonstrates exceptional financial health with industry-leading profitability metrics (89.8% gross margin, 35.4% net margin) and strong growth (20% revenue YoY, 51.2% net income YoY). The company generates substantial free cash flow ($216.9M, 43.4% FCF margin) with zero debt and fortress-like balance sheet strength (6.63x current ratio), positioning it as a highly efficient, cash-generative business with substantial reinvestment capacity.
Strengths
- Exceptional profitability: 89.8% gross margin and 35.4% net margin indicate strong pricing power and operational efficiency
- Accelerating earnings: 51.2% YoY net income growth substantially outpaces 20% revenue growth, demonstrating operating leverage
- Fortress balance sheet: $979.3M equity, zero debt, $64.8M cash, and 6.63x current ratio provide strategic flexibility
- High-quality revenue growth: 20% YoY revenue growth in software/services segment with improving unit economics
- Exceptional cash generation: $216.9M operating cash flow (43.4% FCF margin) with zero capex intensity
- Strong capital efficiency: 18.1% ROE and 15.3% ROA demonstrate superior asset utilization
Risks
- Concentration risk: Heavy dependence on physician network and healthcare sector cyclicality could impact growth
- Margin sustainability: Exceptional net margins (35.4%) may face pressure from increased competition or margin normalization
- Low debt capacity: While zero debt is conservative, lack of financial leverage may indicate underutilization of capital structure
- Market saturation: Penetration of US physician market may eventually limit organic growth acceleration rates
- Regulatory risk: Healthcare sector exposure creates ongoing compliance and regulatory compliance burden
Key Metrics to Watch
- Revenue growth rate sustainability and year-over-year trend deceleration/acceleration
- Operating margin progression and gross margin stability amid competitive pressures
- Free cash flow conversion rate and capital allocation decisions (buybacks, M&A, or dividends)
- Customer retention rates and new customer acquisition trends in core physician platform
- Net income growth rate relative to revenue growth and operating leverage sustainability
Financial Metrics
Revenue
499.5M
Net Income
176.9M
EPS (Diluted)
$0.88
Free Cash Flow
216.9M
Total Assets
1.2B
Cash
64.8M
Profitability Ratios
Gross Margin
89.8%
Operating Margin
38.1%
Net Margin
35.4%
ROE
18.1%
ROA
15.3%
FCF Margin
43.4%
Balance Sheet & Liquidity
Current Ratio
6.63x
Quick Ratio
6.63x
Debt/Equity
0.00x
Debt/Assets
15.4%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-23T16:50:11.854921 |
Data as of: 2025-12-31 |
Powered by Claude AI